FYN siRNA (Mouse)
Référence MBS828203-15nmol
Conditionnement : 15nmol
Marque : MyBiosource
FYN siRNA – Tyrosine-Protein Kinase Fyn Isoform B (Mouse)
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS828203MBS828203 is an siRNA targeting FYN. Also known as FYN siRNA (Mouse). Reactive in Mouse. Host: Synthetic. siRNA to inhibit FYN expression using RNA interference More details
Product Overview
Online Datasheet in PDFProduct Name
FYN, siRNA
Full Product Name
FYN siRNA (Mouse)
Product Gene Name
FYN sirna
Product Synonym Names
Tyrosine-protein kinase Fyn; Proto-oncogene c-Fyn; p59-Fyn
Host
Synthetic
Species Reactivity
Mouse
Form/Format
Lyophilized powder
Purity/Purification
> 97%
Specificity
FYN siRNA (Mouse) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
Preparation and Storage
Shipped at 4 degree C. Store at -20 degree C for one year.
Molecular Weight
60,059 Da
Negative Control
siRNA Negative Control (Catalog# MBS8241404) is a non-targeting 21 nt siRNA recommended as a negative control for experiments using targeted siRNA transfection.
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use
We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components
We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of mouse FYN gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo.
Applications Tested/Suitable for FYN sirna
RNA Interference (RNAi)
Other Notes
Small volumes of FYN sirna vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for FYN. It may not necessarily be applicable to this product.
NCBI Official Full Name
tyrosine-protein kinase Fyn isoform b
NCBI Official Synonym Full Names
Fyn proto-oncogene
NCBI Official Symbol
Fyn
NCBI Official Synonym Symbols
AI448320; AW552119
UniProt Protein Name
Tyrosine-protein kinase Fyn
UniProt Synonym Protein Names
Proto-oncogene c-Fyn; p59-Fyn
Protein Family
Tyrosine-protein kinase
UniProt Gene Name
Fyn
UniProt Entry Name
FYN_MOUSE
NCBI Protein Information
tyrosine-protein kinase Fyn
UniProt Comments for FYN
Fyn: a tyrosine kinase of the Src family. Implicated in the control of cell growth. Plays a role in the regulation of intracellular calcium levels. Required in brain development and mature brain function with important roles in the regulation of axon growth, axon guidance, and neurite extension. Blocks axon outgrowth and attraction induced by NTN1 by phosphorylating its receptor DDC. Associates with the p85 subunit of phosphatidylinositol 3-kinase and interacts with the fyn-binding protein. Three alternatively spliced isoforms have been described. Isoform 2 shows a greater ability to mobilize cytoplasmic calcium than isoform 1. Induced expression aids in cellular transformation and xenograft metastasis. In squamous cell carcinoma, Fyn transduces signals from EGFR and Src and is required for cell migration and invasiveness. Activity linked to migration in a murine melanoma model. Appears to block late stage development of neuroblastoma. Mouse knockout deficient in kindling response, a model for human epilepsy.
Protein type: Kinase, protein; Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; Protein kinase, TK; Oncoprotein; TK group; Src family
Cellular Component: extrinsic to internal side of plasma membrane; mitochondrion; membrane; intracellular membrane-bound organelle; cytoplasm; postsynaptic density; plasma membrane; actin filament; nucleus; endosome; lipid raft
Molecular Function: tubulin binding; CD8 receptor binding; ephrin receptor binding; metal ion binding; nucleotide binding; non-membrane spanning protein tyrosine kinase activity; protein kinase activity; transferase activity; protein binding; G-protein-coupled receptor binding; peptide hormone receptor binding; protein-tyrosine kinase activity; transferase activity, transferring phosphorus-containing groups; protein complex binding; T cell receptor binding; phosphoinositide 3-kinase binding; kinase activity; glycoprotein binding; CD4 receptor binding; ATP binding; receptor binding
Biological Process: myelination; peptidyl-tyrosine phosphorylation; protein amino acid autophosphorylation; multicellular organismal development; neuron migration; protein amino acid phosphorylation; T cell receptor signaling pathway; regulation of apoptosis; regulation of cell shape; cell surface receptor linked signal transduction; forebrain development; negative regulation of neuron apoptosis; positive regulation of I-kappaB kinase/NF-kappaB cascade; immune system process; dendrite morphogenesis; activated T cell proliferation; regulation of cell proliferation; positive regulation of phosphoinositide 3-kinase cascade; detection of mechanical stimulus involved in sensory perception of pain; response to ethanol; innate immune response; negative regulation of protein ubiquitination; negative regulation of protein catabolic process; phosphorylation; transmembrane receptor protein tyrosine kinase signaling pathway
Show more Protein type: Kinase, protein; Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; Protein kinase, TK; Oncoprotein; TK group; Src family
Cellular Component: extrinsic to internal side of plasma membrane; mitochondrion; membrane; intracellular membrane-bound organelle; cytoplasm; postsynaptic density; plasma membrane; actin filament; nucleus; endosome; lipid raft
Molecular Function: tubulin binding; CD8 receptor binding; ephrin receptor binding; metal ion binding; nucleotide binding; non-membrane spanning protein tyrosine kinase activity; protein kinase activity; transferase activity; protein binding; G-protein-coupled receptor binding; peptide hormone receptor binding; protein-tyrosine kinase activity; transferase activity, transferring phosphorus-containing groups; protein complex binding; T cell receptor binding; phosphoinositide 3-kinase binding; kinase activity; glycoprotein binding; CD4 receptor binding; ATP binding; receptor binding
Biological Process: myelination; peptidyl-tyrosine phosphorylation; protein amino acid autophosphorylation; multicellular organismal development; neuron migration; protein amino acid phosphorylation; T cell receptor signaling pathway; regulation of apoptosis; regulation of cell shape; cell surface receptor linked signal transduction; forebrain development; negative regulation of neuron apoptosis; positive regulation of I-kappaB kinase/NF-kappaB cascade; immune system process; dendrite morphogenesis; activated T cell proliferation; regulation of cell proliferation; positive regulation of phosphoinositide 3-kinase cascade; detection of mechanical stimulus involved in sensory perception of pain; response to ethanol; innate immune response; negative regulation of protein ubiquitination; negative regulation of protein catabolic process; phosphorylation; transmembrane receptor protein tyrosine kinase signaling pathway
Research Articles on FYN
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with FYN sirna
| Reference Product | PubMed Publications |
|---|---|
| Cbl sirna | >67 publications with FYN and Cbl |
| Crk sirna | >61 publications with FYN and Crk |
| Fyb sirna | >48 publications with FYN and Fyb |
| Cav1 sirna | >24 publications with FYN and Cav1 |
| Shc1 sirna | >15 publications with FYN and Shc1 |
| Bcar1 sirna | >14 publications with FYN and Bcar1 |
| Khdrbs1 sirna | >12 publications with FYN and Khdrbs1 |
| Nphs1 sirna | >1 publications with FYN and Nphs1 |
| Ctnnd1 sirna | >1 publications with FYN and Ctnnd1 |
Pathways associated with FYN sirna
| Products by Pathway | Pathway Diagram |
|---|---|
| ARMS-mediated Activation Pathway antibodies | ARMS-mediated Activation Pathway Diagram |
| Adaptive Immune System Pathway antibodies | Adaptive Immune System Pathway Diagram |
| Adherens Junction Pathway antibodies | Adherens Junction Pathway Diagram |
| Adherens Junction Pathway antibodies | Adherens Junction Pathway Diagram |
| Alpha6-Beta4 Integrin Signaling Pathway antibodies | Alpha6-Beta4 Integrin Signaling Pathway Diagram |
| Antigen Activates B Cell Receptor (BCR) Leading To Generation Of Second Messengers Pathway antibodies | Antigen Activates B Cell Receptor (BCR) Leading To Generation Of Second Messengers Pathway Diagram |
| Axon Guidance Pathway antibodies | Axon Guidance Pathway Diagram |
| Axon Guidance Pathway antibodies | Axon Guidance Pathway Diagram |
| Axon Guidance Pathway antibodies | Axon Guidance Pathway Diagram |
| B Cell Receptor Signaling Pathway antibodies | B Cell Receptor Signaling Pathway Diagram |
Diseases associated with FYN sirna
| Disease Name | Pubmed Publications |
|---|---|
| Nervous System Diseases Antibodies | >190 publications with FYN and Nervous System Diseases |
| Inflammation Antibodies | >88 publications with FYN and Inflammation |
| Cell Transformation, Neoplastic Antibodies | >49 publications with FYN and Cell Transformation, Neoplastic |
| Breast Neoplasms Antibodies | >48 publications with FYN and Breast Neoplasms |
| Neoplasms, Experimental Antibodies | >48 publications with FYN and Neoplasms, Experimental |
| Necrosis Antibodies | >44 publications with FYN and Necrosis |
| Kidney Diseases Antibodies | >31 publications with FYN and Kidney Diseases |
| Lung Diseases Antibodies | >31 publications with FYN and Lung Diseases |
| Neoplasm Metastasis Antibodies | >22 publications with FYN and Neoplasm Metastasis |
| Carcinoma, Squamous Cell Antibodies | >21 publications with FYN and Carcinoma, Squamous Cell |
Organs/Tissues associated with FYN sirna
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >793 publications with FYN and Blood |
| Brain Antibodies | >469 publications with FYN and Brain |
| Muscle Antibodies | >94 publications with FYN and Muscle |
| Kidney Antibodies | >86 publications with FYN and Kidney |
| Thymus Antibodies | >75 publications with FYN and Thymus |
| Bone Marrow Antibodies | >75 publications with FYN and Bone Marrow |
| Lung Antibodies | >67 publications with FYN and Lung |
| Liver Antibodies | >60 publications with FYN and Liver |
| Embryonic Tissue Antibodies | >53 publications with FYN and Embryonic Tissue |
| Spleen Antibodies | >52 publications with FYN and Spleen |


